- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02229370
Carotid Aneurysm Registry (CAR)
Extracranial Carotid Artery Aneurysm Registry
Study Overview
Status
Conditions
Detailed Description
CAR is a prospective observational study, initiated by the Department of Vascular Surgery at University Medical Centre Utrecht (UMCU), The Netherlands. The study is descriptive in nature. The registry will be conducted according to the principles of the Declaration of Helsinki (64th WMA General Assembly, Fortaleza, Brazil, October 2013). The medical ethics committee of the UMCU has approved the study and all patients must give written informed consent before enrollment. Study enrolment is open to any patient diagnosed with an ECAA and ongoing.
Enrollment criteria: Participation in the CAR is intended for all subjects diagnosed with an ECAA irrespective of chosen treatment. Aneurysms are defined as 150% dilatation of the normal vessel diameter, or any saccular aneurysm. To be included, aneurysms must be located in the CCA, the external carotid artery or in the extracranial part of the ICA.To be included in the registry, patients need to be 18 years old. There are no additional exclusion criteria.
Intervention and follow-up:CAR does not interfere with the physician's treatment decision. Follow-up visits and imaging studies are scheduled as usual in their clinical practice, as this study does also not interfere with or influence the follow-up regimen.
Study endpoints:The primary endpoint of the CAR is freedom from aneurysm related symptoms at 30 days and at mid- and longterm follow-up. The secondary endpoint comprises treatment safety.
Endpoint monitoring:An endpoint adjudication committee, consisting of clinical experts, is set up to harmonize and standardize endpoint assessment and to determine whether the endpoints meet described criteria. This committee will review important subjective endpoints reported by trial investigators. The members of this committee are blinded to the treatment regime.
Data collection and monitoring: Data collected will be recorded through a web-based case report form (CRF). Data will be collected at baseline, at the moment of intervention, at the 30-day (or first postoperative) visit and during the follow-up phase. Data will remain at the UMCU in a secure environment.
This registry is a multicenter study. Statistical analysis: Statistical analyses will be performed using SPSS software.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Gert Jan de Borst, MD, PhD
- Phone Number: +31-88-7556965
- Email: g.j.deBorst-2@umcutrecht.nl
Study Locations
-
-
-
Utrecht, Netherlands, 3508 GA
- Recruiting
- University Medical Center Utrecht
-
Contact:
- Gert Jan de Borst, MD, PhD
- Phone Number: +31-88-7556965
- Email: g.j.deBorst-2@umcutrecht.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Individual has one or more aneurysms of the extracranial carotid artery. Defined as 150% dilatation of the normal vessel diameter, or any saccular aneurysm.
- Individual is ≥18 years of age.
- Individual has signed informed consent
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
ECAA
all patients diagnosed with an extracranial carotid artery aneurysm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
aneurysms related symptoms
Time Frame: 5 years
|
Aneurysm related symptoms such as ipsilateral stroke, TIA or compression.
Disability is assessed by the Rankin scale.
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of peri- and postoperative complications.
Time Frame: 30 days
|
Treatment safety includes peri- and postoperative complications and registration of reinterventions performed within 30days after initial treatment.
Complications include peripheral nerve dysfunction, local hematoma or infection, local pain or headache, TIA, stroke, local bleeding or aneurysm rupture and all-cause mortality.
|
30 days
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Welleweerd JC, Bots ML, Kappelle LJ, Rinkel GJ, Ruigrok YM, Baas AF, van der Worp HB, Vergouwen MD, Bleys RL, Hendrikse J, Lo TR, Moll FL, de Borst GJ. Rationale and design of the extracranial Carotid artery Aneurysm Registry (CAR). J Cardiovasc Surg (Torino). 2018 Oct;59(5):692-698. doi: 10.23736/S0021-9509.16.08637-7. Epub 2015 Feb 6.
- Welleweerd JC, de Borst GJ; Carotid Aneurysm Registry Project Group. Extracranial carotid artery aneurysm: optimal treatment approach. Eur J Vasc Endovasc Surg. 2015 Mar;49(3):235-6. doi: 10.1016/j.ejvs.2014.11.007. Epub 2014 Dec 9. No abstract available.
- Welleweerd JC, Nelissen BG, Koole D, de Vries JP, Moll FL, Pasterkamp G, Vink A, de Borst GJ. Histological analysis of extracranial carotid artery aneurysms. PLoS One. 2015 Jan 30;10(1):e0117915. doi: 10.1371/journal.pone.0117915. eCollection 2015.
- Welleweerd JC, de Borst GJ, de Groot D, van Herwaarden JA, Lo RT, Moll FL. Bare metal stents for treatment of extracranial internal carotid artery aneurysms: long-term results. J Endovasc Ther. 2015 Feb;22(1):130-4. doi: 10.1177/1526602814566405.
- Welleweerd JC, Moll FL, de Borst GJ. Technical options for the treatment of extracranial carotid aneurysms. Expert Rev Cardiovasc Ther. 2012 Jul;10(7):925-31. doi: 10.1586/erc.12.61.
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAR2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Extracranial Carotid Artery Aneurysm
-
UMC UtrechtRecruitingExtracranial Carotid Artery AneurysmNetherlands
-
Boston Scientific CorporationNot yet recruitingExtracranial Carotid Artery Disease | TCAR | Transcarotid Artery Revascularization
-
John Paul II Hospital, KrakowUnknownCarotid Artery AneurysmPoland
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloUnknownCerebral Aneurysm | Brain Aneurysm | Aneurysm, Middle Cerebral Artery | Aneurysm, Anterior Communicating Artery | Aneurysm, Posterior Communicating Artery | Aneurysm, Carotid ArteryBrazil
-
Tartu University HospitalCompletedPeripheral Artery Disease | Abdominal Aortic Aneurysm | Carotid Artery StenosisEstonia
-
Universitair Ziekenhuis BrusselTerminatedCarotid Artery Plaque | Aneurysm | Aortic AneurysmBelgium
-
Erik DebingCompletedAbdominal Aortic Aneurysm | Carotid Artery Stenosis | EpidemiologyBelgium
-
Philips Clinical & Medical Affairs GlobalCompletedCarotid Stenosis | Abdominal Aortic Aneurysm (AAA) | Thoracic Aortic Aneurysm (TAA) | Visceral Artery AneurysmUnited States
-
Seoul National University HospitalSamsung Medical Center; Asan Medical Center; Seoul National University Bundang... and other collaboratorsActive, not recruitingUnruptured Aneurysm of Carotid ArteryKorea, Republic of
-
University of MiamiTemporarily not availablePseudoaneurysm, Carotid | PseudoaneurysmUnited States